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the antibiotics. How many patients were on antibiotics for 6, 8, 12
weeks? And if so, which antibiotics? I couldn’t quite read your slide.
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Dr Michael Singh (Rochester, NY). The authors have deter-
mined that thoracic endovascular aneurysm repair (TEVAR) for aor-
tobronchial fistulas (ABFs) is technically feasible and has acceptable
short-term results. In 9 years, 19 cases presented at your institution,
and 11 underwent endovascular repair. Of the 11 cases, computed
tomography (CT) imaging was performed preoperatively, which de-
fined aortic pathology but failed to diagnose the fistula. Six of 11
underwent bronchoscopy, with the origin of bleeding located in five
of six patients. My questions are: How was the aortobronchial fistula
diagnosismade in the six patientswhodid not undergo bronchoscopy
or had a negative endoscopy? In an era of advanced endovascular
therapy, can you explainwhy stacked abdominal aortic cuffs were used
in three patients? In reviewing your manuscript, 8 of 11 patients were
followed for a time frame of 6months or less. Do you have any recent
data on these patients, specifically looking at mortality and the occur-
rence of graft infections?
Dr Charles J. Bailey. For the six individuals who did not have
ABF diagnosed with bronchoscopy, looking back through the case
series, these are often patients who are not admitted primarily to
the vascular or thoracic surgery service. There is a fair number that
were admitted to the medical service. So the index of suspicion is
not there. And I think for the six that once they are brought to the
consultation of our service, given the fact that they had docu-
mented CT angiography, they have thoracic pathology, the pres-
ence of ongoing hemoptysis not explained otherwise, I think it was
purely clinical suspicion that led to the diagnosis. And certainly if
you look after TEVAR, the hemoptysis is resolved, I guess in
hindsight it was an accurate judgment.
Secondly, for the stacked aortic cuffs, one thing that Pachucki
had mentioned in his work, in looking back at the progression of
these ABFs, is you have one episode of hemoptysis and the track
stays a certain size. And as these events progress, or if they are
unrecognized, that defect enlarges. And I think Dr Veeraswamy
could comment better on the necessity of putting multiple stents
in. I think it was to adequately cover not only the defect but to
ensure there was not an endoleak at completion.
We do not have any additional follow-up than we reported
here. But certainly long-term follow-up will be needed to validate
this as an effective therapy.
Dr Anil Hingorani (Brooklyn, NY). I wanted to ask you aboutDr Bailey. There was a preface to that, kind of the regimen or
he protocol that is used once we have determined there is ABF is
ll patients receive perioperative cephalosporins. All patients get
urveillance blood cultures prior to stent deployment. Two pa-
ients were on long-term antibiotics, meaning6 weeks, one with
methicillin-resistant Staphylococcus aureus (MRSA) bacteremia,
he second one who had a vent-associated pneumonia. The MRSA
as treated with vancomycin. The vent-associated pneumonia was
reated with Levaquin for 6 weeks duration.
We have maintained a selective antibiotic regimen, meaning
hat unless there is documented bacteremia or another source of
epsis, the patients are not routinely sent home on prolonged
egimens of antibiotics. And to this point we don’t have any
ocumented evidence of end ostent infection.
Dr Hingorani. I would find that troubling, because there are
ome case reports in the literature with aortoenteric fistulas that
ere not put on antibiotics for long-term, permanent in some
ases, where they ended up with reinfections and having to have
einterventions, which are disastrous. That was, I guess, based
pon your infectious disease consult perhaps?
Dr Bailey:Correct. A combination of that and if you look at the
eports, though limited, when broaching the topic of long-term
ntibiotics, most studies have felt that the flora in the pulmonary
ystem ismarkedly less thanwith an aortoenteric fistula and that without
ocumented sources they didn’t feel compelled to treat them.
Dr Ravi Veeraswamy. We were sort of surprised when we
ooked back that this is what the data had shown. I think one of the
hings that we are hypothesizing is that we had a very short delay
etween the time of diagnosis and the placement of the stent graft.
nd you could theorize that maybe we were able to seal it sooner and
o on.
The other reason we didn’t put them on long-term antibiotics
as it was very unclear in conjunction with our infectious disease
olleagues exactly what we would use and what the optimal therapy
ould be. And so as this sort of developed, the first couple of patients
ere not put on antibiotics and they did okay for 1 month and 3
onths and 6 months and so on, so we adopted that algorithm. But
t is something thatwe are looking atwith each case that comes in, and
ertainly I would agree with you that it is surprising.
And then just to clarify the answer to Michael, we did see the
stula ultimately when we did the angiogram. The point is that we
idn’t see it preprocedurally.
